OVID Ovid Therapeutics Inc.
Fundamentals / CIK 0001636651 / USDOvid Therapeutics Inc. reported $1.45M in revenue and a net loss of $43.11M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -4700.3% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OVID in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$1.45M -100.0% YoY
-
Operating Income TTM-$68.20M -4700.3% margin
-
Net Income TTM-$43.11M -2971.3% net margin
-
Diluted EPS TTM-- Split-adjusted
-
Free Cash Flow TTM-$38.33M -2641.9% FCF margin
-
Cash & ST Investments Sep 30, 2026$136.6M Total debt: $12.35M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.25M | $566K | $392K | $1.50M | $208.4M | $12.62M | -- | -- | -- | -- |
| Research & Development | $25.58M | $36.77M | $28.59M | $24.62M | $46.94M | $63.42M | $42.16M | $33.79M | $49.97M | $9.59M |
| Total Operating Expenses | $49.69M | $62.45M | $59.67M | $57.05M | $84.17M | $94.05M | $61.41M | $52.93M | $65.01M | $22.54M |
| Operating Income | -$42.44M | -$61.88M | -$59.28M | -$55.55M | $124.2M | -$81.43M | -$61.41M | -$52.93M | -$65.01M | -$22.54M |
| EBITDA | -$42.17M | -$61.27M | -$58.71M | -$55.04M | $124.4M | -$81.12M | -$61.15M | -$52.79M | -$64.93M | -$22.48M |
| Interest Income | $2.03M | $3.92M | $4.94M | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$17.41M | -$26.43M | -$52.34M | -$54.17M | $124.2M | -$81.04M | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $1.33M | $0 | $0 | $0 | $0 | -- |
| Net Income | -$17.41M | -$26.43M | -$52.34M | -$54.17M | $122.8M | -$81.04M | -$60.46M | -$51.98M | -$64.81M | -$22.41M |
| Basic EPS | -- | -- | -$0.74 | -$0.77 | $1.78 | -$1.39 | -- | -$2.11 | -$3.35 | -$2.28 |
| Diluted EPS | -- | -- | -$0.74 | -$0.77 | $1.76 | -$1.39 | -- | -$2.11 | -$3.35 | -$2.28 |
| Basic Shares Outstanding | -- | -- | 70.6M | 70.4M | 67.5M | 58.5M | -- | 24.6M | 19.3M | 9.8M |
| Diluted Shares Outstanding | -- | -- | 70.6M | 70.4M | 68.1M | 58.5M | -- | 24.6M | 19.3M | 9.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $733K | $0 | $718K | $132K | $6.27M | $130K | $76K |
| Research & Development | $15.70M | $9.96M | $11.18M | $6.59M | $5.87M | $6.46M | $6.66M | $5.92M |
| Total Operating Expenses | $22.36M | $16.43M | $17.85M | $13.01M | $12.65M | $11.35M | $12.68M | $10.80M |
| Operating Income | -$22.36M | -$15.70M | -$17.85M | -$12.29M | -$12.52M | -$5.07M | -$12.55M | -$10.72M |
| EBITDA | -$22.35M | -$15.68M | -$17.81M | -$12.28M | -$12.51M | -$4.97M | -$12.41M | -$10.56M |
| Interest Income | $1.50M | $1.56M | $737K | $847K | $303K | $384K | $491K | $650K |
| Income Before Tax | -$20.78M | -$15.01M | -$16.99M | $9.66M | -$12.16M | -$4.68M | -$10.23M | -$9.25M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$20.78M | -$15.01M | -$16.99M | $9.66M | -$12.16M | -$4.68M | -$10.23M | -$9.25M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $13.15M | $26.30M | $27.04M | $44.87M | $187.8M | $72.03M | $41.90M | $36.49M | $87.13M | $51.94M |
| Short-Term Investments | $56.48M | $26.77M | $78.79M | $84.13M | $0 | -- | $34.84M | $5.01M | -- | -- |
| Cash & Short-Term Investments | $90.45M | $53.08M | $105.8M | $129.0M | $187.8M | $72.03M | $76.70M | $41.50M | $87.13M | $51.94M |
| Total Current Assets | $74.37M | $55.94M | $109.6M | $131.4M | $190.5M | $74.84M | $79.81M | $44.27M | $88.59M | $52.41M |
| Property, Plant & Equipment, Net | $252K | $433K | $769K | $1.15M | $243K | $136K | $68K | $70K | $52K | $44K |
| Intangible Assets | $0 | $100K | $200K | $222K | $164K | $319K | $467K | $392K | $124K | $110K |
| Long-Term Investments | $20.81M | $20.97M | $17.63M | $5.62M | $1.63M | $0 | -- | -- | -- | -- |
| Other Non-Current Assets | $0 | $92K | $210K | $261K | $260K | $319K | $467K | $392K | $124K | $165K |
| Total Non-Current Assets | $76.57M | $36.23M | $34.43M | $23.89M | $4.07M | $1.08M | $1.03M | $3.38M | $870K | $617K |
| Total Assets | $150.9M | $92.17M | $144.0M | $155.3M | $194.5M | $75.93M | $80.84M | $47.65M | $89.46M | $53.03M |
| Accounts Payable | $1.96M | $3.19M | $3.70M | $1.95M | $7.13M | $5.45M | $3.26M | $3.76M | $2.03M | $857K |
| Deferred Revenue (Current) | -- | -- | -- | -- | $0 | $2.21M | -- | -- | -- | -- |
| Total Current Liabilities | $8.29M | $10.52M | $11.47M | $6.99M | $14.80M | $22.06M | $10.53M | $8.84M | $6.02M | $3.73M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $0 | $10.17M | -- | -- | -- | -- |
| Total Non-Current Liabilities | $11.99M | $13.42M | $44.76M | $16.00M | $0 | $10.23M | $287K | $0 | $0 | $0 |
| Total Liabilities | $20.27M | $23.94M | $56.23M | $22.99M | $14.80M | $32.29M | $10.82M | $8.84M | $6.02M | $3.73M |
| Total Debt (incl. Leases) | $13.42M | $14.76M | $16.00M | $16.54M | -- | -- | -- | -- | -- | -- |
| Common Stock | $130K | $71K | $71K | $70K | $70K | $66K | $55K | $25K | $25K | $9.8K |
| Retained Earnings | -$321.7M | -$304.3M | -$277.9M | -$225.5M | -$171.4M | -$294.2M | -$213.2M | -$152.7M | -$100.7M | -$35.91M |
| Accumulated Other Comp. Income | -$202K | -$35K | $1.0K | -$42K | $0 | -- | $2.5K | -$1.8K | -- | -- |
| Total Stockholders' Equity | $130.7M | $68.23M | $87.80M | $132.3M | $179.7M | $43.63M | $70.02M | $38.81M | $83.44M | $49.29M |
| Total Equity | $130.7M | $68.23M | $87.80M | $132.3M | $179.7M | $43.63M | $70.02M | $38.81M | $83.44M | $49.29M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $13.81M | $11.33M | $94.06M | $13.15M | $20.61M | $28.41M | $21.14M | $26.30M |
| Short-Term Investments | $122.8M | $105.9M | $61.46M | $56.48M | $4.99M | $9.93M | $21.86M | $26.77M |
| Cash & Short-Term Investments | $161.4M | $169.8M | $165.6M | $90.45M | $25.60M | $38.35M | $43.00M | $53.08M |
| Total Current Assets | $142.0M | $123.6M | $160.1M | $74.37M | $28.82M | $42.09M | $45.92M | $55.94M |
| Property, Plant & Equipment, Net | $186K | $201K | $217K | $252K | $269K | $285K | $346K | $433K |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $38K | $100K |
| Long-Term Investments | $24.82M | $52.55M | $10.08M | $20.81M | $20.91M | $20.91M | $20.91M | $20.97M |
| Other Non-Current Assets | -- | -- | -- | $0 | $0 | $0 | $39K | $92K |
| Total Non-Current Assets | $80.29M | $108.4M | $65.48M | $76.57M | $35.02M | $35.34M | $35.73M | $36.23M |
| Total Assets | $222.2M | $232.0M | $225.6M | $150.9M | $63.85M | $77.43M | $81.65M | $92.17M |
| Accounts Payable | $5.86M | $4.07M | $8.88M | $1.96M | $1.71M | $3.95M | $1.95M | $3.19M |
| Total Current Liabilities | $11.86M | $9.98M | $15.75M | $8.29M | $6.80M | $8.92M | $9.31M | $10.52M |
| Total Non-Current Liabilities | $11.71M | $12.10M | $11.61M | $11.99M | $12.35M | $12.71M | $13.07M | $13.42M |
| Total Liabilities | $23.57M | $22.08M | $27.36M | $20.27M | $19.15M | $21.64M | $22.38M | $23.94M |
| Total Debt (incl. Leases) | $12.35M | $12.71M | $13.07M | $13.42M | $13.76M | $14.10M | $14.43M | $14.76M |
| Common Stock | $189K | $185K | $167K | $130K | $71K | $71K | $71K | $71K |
| Retained Earnings | -$374.5M | -$353.7M | -$338.7M | -$321.7M | -$331.4M | -$319.2M | -$314.5M | -$304.3M |
| Accumulated Other Comp. Income | -$1.03M | -$750K | -$422K | -$202K | -$126K | -$69K | -$47K | -$35K |
| Total Stockholders' Equity | $198.7M | $209.9M | $198.3M | $130.7M | $44.70M | $55.79M | $59.28M | $68.23M |
| Total Equity | $198.7M | $209.9M | $198.3M | $130.7M | $44.70M | $55.79M | $59.28M | $68.23M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$17.41M | -$26.43M | -$52.34M | -$54.17M | $122.8M | -$81.04M | -$60.46M | -$51.98M | -$64.81M | -$22.41M |
| Depreciation & Amortization | $273K | $613K | $568K | $513K | $237K | $307K | $255K | $142K | $80K | $57K |
| Stock-Based Compensation | $4.81M | $6.28M | $7.29M | $6.56M | $5.05M | $7.53M | $5.21M | $7.06M | $6.40M | $3.64M |
| Change in Payables | -$1.23M | -$512K | $1.75M | -$5.17M | $1.70M | $2.33M | -$654K | $1.65M | $1.08M | $187K |
| Operating Cash Flow | -$38.33M | -$55.96M | -$45.78M | -$55.23M | $118.6M | -$51.58M | -$51.09M | -$45.56M | -$31.47M | -$17.80M |
| Capital Expenditure | $0 | -$71K | -$40K | -$1.22M | -$184K | -$127K | -$57K | -$34K | -$39K | -$30K |
| Free Cash Flow | -$38.33M | -$56.03M | -$45.82M | -$56.45M | $118.4M | -$51.71M | -$51.15M | -$45.59M | -$31.51M | -$17.83M |
| Purchases of Investments | -$91.85M | -$73.25M | -$112.4M | -$173.0M | $0 | -$9.96M | -$34.80M | -$50.01M | -- | -- |
| Investing Cash Flow | -$49.85M | $54.59M | -$2.58M | -$87.88M | -$1.82M | $34.65M | -$30.04M | -$5.36M | -$47K | -$189K |
| Common Stock Issued | -- | -- | -- | -- | $0 | $46.73M | $64.12M | -- | -- | -- |
| Financing Cash Flow | $75.21M | $622K | $30.54M | $181K | $904K | $47.07M | $86.54M | $286K | $66.70M | -$14K |
| Net Change in Cash | -$13.15M | -$740K | -$17.83M | -$142.9M | $117.7M | $30.14M | $5.41M | -$50.64M | $35.19M | -$18.00M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$20.78M | -$15.01M | -$16.99M | $9.66M | -$12.16M | -$4.68M | -$10.23M | -$9.25M |
| Depreciation & Amortization | $15K | $16K | $35K | $17K | $16K | $99K | $141K | $160K |
| Stock-Based Compensation | $1.28M | $1.43M | $1.05M | $1.20M | $1.11M | $1.22M | $1.28M | $1.26M |
| Change in Payables | $1.78M | -$1.51M | $3.62M | $246K | -$2.24M | $2.00M | -$1.24M | $481K |
| Operating Cash Flow | -$15.88M | -$17.59M | -$13.90M | -$10.41M | -$12.87M | -$4.77M | -$10.28M | -$10.01M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | -$22K |
| Free Cash Flow | -- | -- | -- | -$10.41M | -$12.87M | -$4.77M | -$10.28M | -$10.03M |
| Purchases of Investments | -$3.85M | -$102.7M | -$4.05M | -$77.06M | -$4.95M | -$4.95M | -$4.90M | -$16.71M |
| Investing Cash Flow | $11.15M | -$86.74M | $5.95M | -$72.06M | $5.05M | $12.05M | $5.10M | $21.29M |
| Common Stock Issued | $8.12M | $1.0K | $2.37M | -- | $0 | $0 | $0 | -- |
| Financing Cash Flow | $7.28M | $21.60M | $88.98M | $75.18M | $15K | $0 | $13K | $0 |
| Net Change in Cash | $2.48M | -$82.74M | $80.91M | -$7.46M | -$7.80M | $7.28M | -$5.17M | $11.28M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -585.2% | -10933.7% | -15122.7% | -3696.4% | 59.6% | -645.4% | -- | -- | -- | -- |
| Net Profit Margin | -240.1% | -4670.1% | -13351.8% | -3604.7% | 58.9% | -642.3% | -- | -- | -- | -- |
| Return on Equity (ROE) | -13.3% | -38.7% | -59.6% | -41.0% | 68.3% | -185.7% | -86.3% | -134.0% | -77.7% | -45.5% |
| Return on Assets (ROA) | -11.5% | -28.7% | -36.3% | -34.9% | 63.1% | -106.7% | -74.8% | -109.1% | -72.4% | -42.3% |
| Current Ratio | 8.97x | 5.32x | 9.55x | 18.79x | 12.87x | 3.39x | 7.58x | 5.01x | 14.71x | 14.04x |
| Quick Ratio | 10.91x | 5.04x | 9.22x | 18.45x | 12.69x | 3.26x | 7.28x | 4.69x | 14.47x | 13.91x |
| Debt to Equity | 0.10x | 0.22x | 0.18x | 0.13x | -- | -- | -- | -- | -- | -- |
| Revenue Growth (YoY) | +1181.3% | +44.4% | -73.9% | -99.3% | +1551.6% | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -144.7% | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -144.1% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -143.3% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -146.6% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -147.7% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4700.3% | -3686.7% | -670.2% | -585.2% | -618.3% | -625.0% | -10404.2% | -10933.2% |
| Net Profit Margin | -2971.3% | -2178.9% | -339.3% | -240.1% | -549.6% | -574.0% | -4557.1% | -4670.0% |
| Return on Equity (ROE) | -21.7% | -16.4% | -12.2% | -13.3% | -81.3% | -68.4% | -42.1% | -38.7% |
| Return on Assets (ROA) | -19.4% | -14.9% | -10.7% | -11.5% | -56.9% | -49.3% | -30.6% | -28.7% |
| Current Ratio | 11.97x | 12.39x | 10.17x | 8.97x | 4.24x | 4.72x | 4.93x | 5.32x |
| Quick Ratio | 13.61x | 17.01x | 10.52x | 10.91x | 3.77x | 4.30x | 4.62x | 5.04x |
| Debt to Equity | 0.06x | 0.06x | 0.07x | 0.10x | 0.31x | 0.25x | 0.24x | 0.22x |
| Revenue Growth (YoY) | -100.0% | -88.3% | -100.0% | +844.7% | -23.7% | +3611.2% | -12.2% | -46.5% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -155.0% | -- | -- |